VictrexLSE:VCT -0.83%71 EBITDA Margin % is -20.46% as of Mar. 2026. GuruFocus rates LSE:VCT with a GF Score™ of 71/100 and a GF Value™ of £9.89 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 1,584 Chemicals companies, Victrex ranks better than 83.65% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Victrex's EBITDA for the
six
months ended in Mar. 2026 was £-30.3 Mil. Victrex's Revenue for the
six
months ended in Mar. 2026 was £148.1 Mil. Therefore, Victrex's EBITDA margin for the quarter that ended in Mar. 2026 was -20.46%.
Victrex (LSE:VCT) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Victrex EBITDA Margin % Related Terms
Victrex EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Victrex's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:VCT vs LIN, SHW, ECL: EBITDA Margin % Comparison
For the Specialty Chemicals subindustry, Victrex's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Victrex EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Victrex's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Victrex's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Victrex (LSE:VCT) has a EBITDA Margin % of -20.46% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Victrex and its competitors. Over the past decade, Victrex's EBITDA Margin % has ranged from 16.31 to 46.06. According to the industry distribution chart, Victrex ranks #259 out of 1584 companies in the Chemicals industry, placing it in the top 16.4%.
Is Victrex's EBITDA Margin % too high?
Victrex's current EBITDA Margin % is -20.46%. Over the past 10 years, this metric has ranged from a low of 16.31 to a high of 46.06. Based on the distribution chart, Victrex ranks #259 out of 1584 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Victrex has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Victrex's EBITDA Margin % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Victrex ranks #259 out of 1584 companies for EBITDA Margin %. This places Victrex in the top 16% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 9.64. Historically, Victrex's own EBITDA Margin % has ranged from 16.31 to 46.06 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.64, based on 1,584 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Victrex and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Victrex's current EBITDA Margin % is -20.46%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Victrex stock overvalued right now?
Based on GuruFocus' analysis, Victrex (LSE:VCT) is currently considered Significantly Undervalued. The stock's GF Value™ is £9.89, compared to a current price of £5.99 — trading 39.4% below its estimated fair value. The current EBITDA Margin % is -20.46%. Victrex's overall GF Score™ is 71/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Victrex (LSE:VCT), the current EBITDA Margin % is -20.46% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Victrex (LSE:VCT) Overvalued in 2026?
Based on GuruFocus' analysis, Victrex stock appears to be undervalued.
The current stock price of £5.99 is trading 39.4% below its estimated GF Value™ of £9.89.
GuruFocus considers Victrex to be Significantly Undervalued.
Key valuation signals for LSE:VCT:
EBITDA Margin %: -20.46%
GF Value™: £9.89 vs. price of £5.99 (39.4% below fair value)
No single metric tells the full story. See the LSE:VCT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Victrex PLC is a British specialty chemicals company whose business is based predominantly on manufacturing and creating solutions using polyetheretherketone, or PEEK, an ultra-high-performance lightweight plastic. The business has two segments. The Sustainable Solutions targets transportation, energy, electronics, and manufacturing, while the Medical Segment provides healthcare solutions for the implantable device markets. Geographically operates in the United Kingdom, Europe, the Middle East and Africa (EMEA), America, and Asia-Pacific. Its maximum sales are generated from the Middle East and Africa (EMEA).
71GF Score
Get the complete analysis for LSE:VCT
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:VCT has been successfully added to your 
